Literature DB >> 17928427

Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development.

Rabia Hussain1, Najeeha Talat, Firdaus Shahid, Ghaffar Dawood.   

Abstract

Household contacts (HCs) of patients with tuberculosis (TB) are at higher risk of infection as well as the development of active disease. Longitudinal tracking of antigen-specific cytokines after acute exposure may significantly advance our understanding of the dynamic changes in cytokine patterns associated with disease establishment. To achieve this objective, we carried out a prospective cohort study with healthy HCs after exposure to TB. The patterns of cytokines (gamma interferon [IFN-gamma] and interleukin 10 [IL-10]) in response to mycobacterial antigens (culture filtrate [CF] proteins) and nonspecific mitogens (phytohemagglutinin [PHA] and lipopolysaccharide [LPS]) were assessed at 0, 6, 12, and 24 months after exposure. Seven of 109 (6.4%) HCs developed active disease. Six of the seven individuals were females, and active disease developed between 12 and 15 months after exposure in 5/20 families. The most significant findings were the exponential increases ( approximately 1,000-fold) in both the CF protein- and the PHA- or LPS-induced IFN-gamma/IL-10 ratio in healthy HCs (n = 26), which peaked at 12 months, compared to the levels in HCs who developed disease (n = 7), in whom relatively flat responses were observed during the 24-month period. Linear trends for 0 to 12 and 0 to 24 months for the CF protein-induced IFN-gamma/IL-10 ratio showed significant differences between the two groups, as determined by the use of the Mantel extension test for chi(2) analysis (odds ratio = 0.45; 95% confidence interval = 0.295 to 0.685; P = 0.0002). Our results strongly suggest that the magnitude of the IFN-gamma/IL-10 ratio at 12 months after exposure may be a critical determinant in the resolution of infection. These studies provide new insights into the cytokine responses associated with disease establishment or the resolution of infection after natural exposure to TB and have implications for TB control programs as well vaccine efficacy studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928427      PMCID: PMC2168383          DOI: 10.1128/CVI.00289-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  49 in total

Review 1.  Clinical practice. Latent tuberculosis infection.

Authors:  Robert M Jasmer; Payam Nahid; Philip C Hopewell
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis.

Authors:  C Lienhardt
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

3.  Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.

Authors:  Katie Ewer; Kerry A Millington; Jonathan J Deeks; Lydia Alvarez; Gerry Bryant; Ajit Lalvani
Journal:  Am J Respir Crit Care Med       Date:  2006-06-23       Impact factor: 21.405

4.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Authors:  V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.

Authors:  A A Pathan; K A Wilkinson; P Klenerman; H McShane; R N Davidson; G Pasvol; A V Hill; A Lalvani
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.

Authors:  Gillian F Black; Rosemary E Weir; Sian Floyd; Lyn Bliss; David K Warndorff; Amelia C Crampin; Bagrey Ngwira; Lifted Sichali; Bernadette Nazareth; Jenefer M Blackwell; Keith Branson; Steven D Chaguluka; Linda Donovan; Elizabeth Jarman; Elizabeth King; Paul E M Fine; Hazel M Dockrell
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

7.  In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.

Authors:  Joanne Turner; Mercedes Gonzalez-Juarrero; Debi L Ellis; Randy J Basaraba; Andre Kipnis; Ian M Orme; Andrea M Cooper
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

8.  Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulnionary tuberculosis cases in Umerkot, Pakistan.

Authors:  S K Rathi; S Akhtar; M H Rahbar; S I Azam
Journal:  Int J Tuberc Lung Dis       Date:  2002-10       Impact factor: 2.373

9.  Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population.

Authors:  Rabia Hussain; Arnawaz Kaleem; Firdaus Shahid; Maqboola Dojki; Bushra Jamil; Hammad Mehmood; Ghaffar Dawood; Hazel M Dockrell
Journal:  J Immunol Methods       Date:  2002-06-01       Impact factor: 2.303

Review 10.  The secret lives of the pathogenic mycobacteria.

Authors:  Christine L Cosma; David R Sherman; Lalita Ramakrishnan
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

View more
  22 in total

1.  Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status.

Authors:  Jacqueline M Achkar; Elisabeth Jenny-Avital; Xian Yu; Susanne Burger; Eric Leibert; Patrick W Bilder; Steven C Almo; Arturo Casadevall; Suman Laal
Journal:  Clin Vaccine Immunol       Date:  2010-01-13

2.  Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis.

Authors:  Seok-Yong Eum; Ye-Jin Lee; Jin-Hong Min; Hyun-Kyung Kwak; Min-Sun Hong; Ji-Hye Kong; Soo-Hee Hwang; Seung-Kyu Park; Jason J Leblanc; Laura E Via; Clifton E Barry; Sang-Nae Cho
Journal:  Respiration       Date:  2010-02-10       Impact factor: 3.580

3.  Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study.

Authors:  Rabia Hussain; Najeeha Talat; Ambreen Ansari; Firdaus Shahid; Zahra Hasan; Ghaffar Dawood
Journal:  J Clin Immunol       Date:  2011-07-14       Impact factor: 8.317

Review 4.  The impact of mucosal infections on acquisition and progression of tuberculosis.

Authors:  S Perry; R Hussain; J Parsonnet
Journal:  Mucosal Immunol       Date:  2011-03-16       Impact factor: 7.313

5.  Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis.

Authors:  Sylvie Bertholet; David J Horne; Elsa M Laughlin; Margery Savlov; Ines Tucakovic; Rhea N Coler; Masahiro Narita; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

6.  Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.

Authors:  Zahra Hasan; Bushra Jamil; Mussarat Ashraf; Muniba Islam; Maqboola Dojki; Muhammad Irfan; Rabia Hussain
Journal:  Clin Vaccine Immunol       Date:  2009-05-13

7.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

8.  IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.

Authors:  Helena del Corral; Sara C París; Nancy D Marín; Diana M Marín; Lucelly López; Hanna M Henao; Teresita Martínez; Liliana Villa; Luis F Barrera; Blanca L Ortiz; María E Ramírez; Carlos J Montes; María C Oquendo; Lisandra M Arango; Felipe Riaño; Carlos Aguirre; Alberto Bustamante; John T Belisle; Karen Dobos; Gloria I Mejía; Margarita R Giraldo; Patrick J Brennan; Jaime Robledo; María P Arbeláez; Carlos A Rojas; Luis F García
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

9.  Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts.

Authors:  Rabia Hussain; Najeeha Talat; Firdaus Shahid; Ghaffar Dawood
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

10.  Infection with Helicobacter pylori is associated with protection against tuberculosis.

Authors:  Sharon Perry; Bouke C de Jong; Jay V Solnick; Maria de la Luz Sanchez; Shufang Yang; Philana Ling Lin; Lori M Hansen; Najeeha Talat; Philip C Hill; Rabia Hussain; Richard A Adegbola; Joanne Flynn; Don Canfield; Julie Parsonnet
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.